exclusion from participation in federal healthcare programs such as Medicare and Medicaid; (25) delays in returning, or failure to return the Company's approved products to market, including loss of market share as a result of the suspension of shipments, and related costs; (26) the ability to sell or license certain assets, and the purchase prices, milestones, terms and conditions of such transac